CCL8 and laryngotracheoesophageal cleft: However, the increase in these biomarkers did not persist at month 6 of the post-infection period, and instead, we saw significantly lower levels in four inflammatory biomarkers (IL2RB, LAPTGFbeta1, MCP2, and MCP4) in LC patients (Figure 6).